ideasIdea
A plain-language explainer for every guideline recommendation, in every major language
For each treatment recommendation in the guidelines, publish a short explanation patients can read in their own language: what it is, why it is recommended, and what the evidence says.
Patient information is written separately from guidelines and lags them. The proposal generates and expert-verifies a patient explainer for each recommendation in a computable guideline (using the structured evidence and plain-language summaries), checked for reading age, translated into at least 20 languages, and updated automatically when the recommendation changes. ESMO patient guides and NCCN patient guidelines are precedents but are updated slowly.
Hypothesis
Patients given recommendation-level explainers will report higher understanding and shared decision-making scores, and will be less likely to follow misinformation, than those receiving general information leaflets.
Rationale
Decision aids improve knowledge and reduce decisional conflict in randomised trials; tying them to the live guideline solves the currency problem that plagues static leaflets.
What would test it
Randomise patients at decision points in two cancers to explainers versus standard leaflets; measure knowledge, decisional conflict and use of unproven treatments.
Maturity
speculative
Who has to act
patients
Cost to try
Small (under $1M)
Years to first evidence
2
Bottlenecks it attacks
- Knowledge reaches practice too slowly · Knowledge diffusion is slow: it takes years for a proven result to change what most patients receive, and no one can keep up with the literature.
- Misinformation and unproven therapies · Patients are sold unproven treatments and frightened away from proven ones.
- Patients lack understanding, navigation and agency · Most patients cannot understand their options, find trials, or push back, so decisions are made for them.